Reference number : 236-2013-2014-Q3-00198, amendment number : , agreement type : G, recipient legal name : BÉRARD, Anick, recipient country : CA, recipient province : QC, recipient city : Montréal, recipient postal code : H3T 1C5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 100000.0, agreement start date : 2013-11-01, agreement end date : 2014-10-31, description english : SNRI, bupropion and mirtazapine use during pregnancy and the risk of persistent pulmonary hypertension of the newborn (PPHN), description french : SNRI, bupropion and mirtazapine use during pregnancy and the risk of persistent pulmonary hypertension of the newborn (PPHN), expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2013-14 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2013-14 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada